Every record from Janoshik · page 17
The single largest contributor to the index and the de facto reference against which the other five labs are calibrated here. Measured offset against the reference laboratory is 0.000 pp. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042513 | Semax | ERP | ERP-2512-G6974 | 2026-Q1 | 99.87 | 8.97 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041629 | BPC-157 | QSC | QSC-2511-N8732 | 2026-Q2 | 99.93 | 5.79 | 107.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043167 | BPC-157 | GL Biochem | GLBI-2602-T8420 | 2026-Q2 | 98.99 | 4.05 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042553 | GHK-Cu | ERP | ERP-2601-F7633 | 2026-Q2 | 98.54 | 4.20 | — | Supplier-supplied | 0 | PASS |
| AX-2026-042524 | Liraglutide | ERP | ERP-2601-P6802 | 2026-Q2 | 98.81 | 5.09 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042735 | Tirzepatide | GGPeps | GGPE-2510-L9923 | 2026-Q1 | 98.39 | 4.54 | 106.4 | Supplier-supplied | 3 | MARGINAL |
| AX-2026-042631 | Semaglutide | GGPeps | GGPE-2603-W8751 | 2026-Q2 | 99.02 | 3.88 | 105.9 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-042019 | Liraglutide | TFC | TFC-2511-E6528 | 2026-Q2 | 98.84 | 3.36 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041814 | Tirzepatide | FGP | FGP-2605-R1831 | 2026-Q2 | 98.01 | 6.19 | 90.1 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042633 | Semaglutide | GGPeps | GGPE-2603-W8751 | 2026-Q2 | 99.65 | 3.50 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042098 | Retatrutide | TFC | TFC-2512-G7985 | 2026-Q2 | 98.60 | 2.38 | 102.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041861 | PT-141 (Bremelanotide) | JEEP | JEEP-2601-K3015 | 2026-Q2 | 99.02 | 4.41 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041676 | Ipamorelin | QSC | QSC-2602-W8804 | 2026-Q1 | 99.93 | 6.14 | 91.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041217 | Thymulin | WWB | WWB-2602-S2129 | 2026-Q2 | 99.12 | 3.60 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042012 | 5-Amino-1MQ | TFC | TFC-2508-L6321 | 2026-Q1 | 99.93 | 5.84 | 95.7 | Supplier-supplied | 0 | FAIL |
| AX-2026-041801 | Tirzepatide | FGP | FGP-2605-R1831 | 2026-Q2 | 97.70 | 7.19 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041594 | Retatrutide | QSC | QSC-2510-H7626 | 2026-Q1 | 98.42 | 3.63 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043018 | Semaglutide | KP | KP-2511-J4998 | 2026-Q2 | 99.93 | 7.57 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042750 | Cagrilintide | GGPeps | GGPE-2603-R9581 | 2026-Q2 | 97.46 | 5.31 | 98.5 | Supplier-supplied | 0 | PASS |
| AX-2026-042627 | BPC-157 | GGPeps | GGPE-2602-E8672 | 2026-Q2 | 98.80 | 3.98 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042199 | Semaglutide | Homopeptide | HOMO-2511-C9607 | 2026-Q1 | 99.13 | 4.23 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042009 | Epitalon | TFC | TFC-2508-W5644 | 2026-Q1 | 98.42 | 7.29 | — | Supplier-supplied | 0 | FAIL |
| AX-2026-041623 | BPC-157 | QSC | QSC-2511-N8732 | 2026-Q2 | 99.93 | 5.81 | 104.3 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042899 | Semax | MKM | MKM-2512-B2992 | 2026-Q2 | 98.52 | 6.55 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041800 | BPC-157 | FGP | FGP-2512-A2448 | 2026-Q1 | 99.79 | 3.90 | 95.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041701 | Semaglutide | QSC | QSC-2604-H9231 | 2026-Q2 | 99.42 | 6.35 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043192 | Exenatide | GL Biochem | GLBI-2509-A8203 | 2026-Q1 | 98.83 | 3.48 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042972 | Retatrutide | KP | KP-2511-K4263 | 2026-Q1 | 96.65 | 3.75 | 107.2 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042567 | Tirzepatide | ERP | ERP-2512-T7433 | 2026-Q2 | 99.11 | 1.29 | 95.8 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042155 | Tirzepatide | Homopeptide | HOMO-2601-N9196 | 2026-Q2 | 98.24 | 5.66 | 103.8 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042000 | Semaglutide | TFC | TFC-2508-A5297 | 2026-Q1 | 98.57 | 4.10 | 99.6 | Laboratory-retained | 1 | MARGINAL |
| AX-2026-041647 | Selank | QSC | QSC-2601-N8430 | 2026-Q1 | 99.93 | 6.22 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041517 | Retatrutide | QYB | QYB-2602-R6263 | 2026-Q2 | 98.09 | 5.43 | 105.6 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041444 | Liraglutide | QYB | QYB-2511-V5143 | 2026-Q2 | 98.75 | 5.63 | 101.4 | Supplier-supplied | 0 | PASS |
| AX-2026-043518 | MGF | BCH | BCH-2511-D7240 | 2026-Q2 | 99.20 | 5.28 | 97.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042780 | Liraglutide | GGPeps | GGPE-2510-C9973 | 2026-Q1 | 99.08 | 4.40 | 89.4 | Supplier-supplied | 3 | MARGINAL |
| AX-2026-042063 | Afamelanotide | TFC | TFC-2601-L7201 | 2026-Q2 | 99.52 | 4.63 | — | Supplier-supplied | 0 | PASS |
| AX-2026-042054 | Tirzepatide | TFC | TFC-2508-L6746 | 2026-Q1 | 98.34 | 1.81 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042044 | Enclomiphene citrate | TFC | TFC-2605-H7009 | 2026-Q2 | 98.84 | 4.60 | — | Supplier-supplied | 1 | FAIL |
| AX-2026-041942 | Semax | TFC | TFC-2602-F4591 | 2026-Q2 | 99.43 | 7.74 | 96.1 | Supplier-supplied | 0 | PASS |